camostat

Known as: N,N-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate methanesulfonate, camostate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Prostasin, a glycosylphosphatidylinositol-anchored serine protease, regulates epithelial sodium channel (ENaC) activity. Sodium… (More)
Is this relevant?
2009
2009
Inhibition of airway epithelial sodium channel (ENaC) function enhances mucociliary clearance (MCC). ENaC is positively regulated… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Camostat mesilate, an orally available proteinase inhibitor, is clinically used for treatment of pancreatitis. Given recent… (More)
Is this relevant?
2001
2001
BACKGROUND & AIMS Proteolytic release and activation of latent transforming growth factor beta (TGF-beta) by the hepatic stellate… (More)
Is this relevant?
1999
1999
CCK exhibits a potent cytoprotective activity against acute gastric lesions, but its role in ulcer healing has been little… (More)
Is this relevant?
1996
1996
The rat pancreatic carcinoma cell line AR4-2J was screened for growth-associated genes linked to the mitogenic effect of the… (More)
Is this relevant?
1994
1994
BACKGROUND/AIMS Bombesin-stimulated plasma cholecystokinin levels decrease after an initial increase despite continuous infusion… (More)
Is this relevant?
1990
1990
The factors operating at the apical side of the endocrine cell releasing cholecystokinin (CCK) were investigated using the… (More)
Is this relevant?
1989
1989
Earlier studies have indicated that lysosomal enzymes such as cathepsin B become redistributed within pancreatic acinar cells… (More)
Is this relevant?
1988
1988
The effects of chronic oral treatment of rats with 400 mg/kg body weight camostat, a synthetic protease inhibitor, on weight gain… (More)
Is this relevant?